Advertisement
U.S. markets closed

Glenmark Pharmaceuticals Limited (GLENMARK.NS)

NSE - NSE Real Time Price. Currency in INR
1,495.15-27.45 (-1.80%)
At close: 03:30PM IST
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
121,000,970
116,354,560
114,319,380
121,741,980
108,060,260
Cost of Revenue
46,736,200
48,790,420
45,866,050
47,781,710
39,966,250
Gross Profit
74,264,770
67,564,140
68,453,330
73,960,270
68,094,010
Operating Expense
64,594,890
61,253,410
57,664,590
55,559,790
50,933,650
Operating Income
9,669,880
6,310,730
10,788,740
18,400,480
17,160,360
Net Non Operating Interest Income Expense
-3,647,880
-5,097,930
-3,420,360
-2,886,640
-3,504,660
Pretax Income
9,443,510
364,950
2,398,420
14,412,460
13,824,750
Tax Provision
19,378,570
18,673,450
3,294,030
4,475,970
4,123,870
Net Income Common Stockholders
-8,751,760
-15,016,680
2,972,450
9,417,110
9,700,380
Diluted NI Available to Com Stockholders
-8,751,760
-15,016,680
2,972,450
9,417,110
9,700,380
Basic EPS
-3.11
-53.22
10.53
33.37
34.38
Diluted EPS
-3.11
-53.22
10.53
33.37
34.38
Basic Average Shares
282,112
282,171
282,168
282,168
282,168
Diluted Average Shares
282,112
282,179
282,168
282,168
282,168
Rent Expense Supplemental
-
626,120
555,990
353,540
378,990
Total Expenses
111,331,090
110,043,830
103,530,640
103,341,500
90,899,900
Net Income from Continuing & Discontinued Operation
-8,751,760
-15,016,680
2,972,450
9,417,110
9,700,380
Normalized Income
-6,405,767
-12,570,435
3,715,044
11,260,507
9,385,322
Interest Income
-
61,760
70,000
94,350
26,470
Interest Expense
3,709,640
5,159,690
3,490,360
2,980,990
3,531,130
Net Interest Income
-3,647,880
-5,097,930
-3,420,360
-2,886,640
-3,504,660
EBIT
13,153,150
5,524,640
5,888,780
17,393,450
17,355,880
EBITDA
18,749,570
11,832,740
12,001,460
22,260,600
21,791,420
Reconciled Cost of Revenue
46,736,200
48,790,420
45,866,050
47,781,710
39,966,250
Reconciled Depreciation
5,596,420
6,308,100
6,112,680
4,867,150
4,435,540
Net Income from Continuing Operation Net Minority Interest
-10,183,170
-18,989,960
-1,697,160
9,417,110
9,700,380
Total Unusual Items Excluding Goodwill
-5,396,290
-9,170,750
-7,731,720
-2,673,770
448,990
Total Unusual Items
-5,396,290
-9,170,750
-7,731,720
-2,673,770
448,990
Normalized EBITDA
24,145,860
21,003,490
19,733,180
24,934,370
21,342,430
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-1,618,887
-2,751,225
-2,319,516
-830,373
133,932